Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Insulin Aspart vs Basal-Bolus in Type 2 Diabetes
NCT00600626Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2004
- Primary completion
- Jul 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 3 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jan 2004; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00600626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600626.